Medicines Patent Pool Launches Search For Next Director 08/01/2018 by William New, Intellectual Property Watch Leave a Comment Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)A negotiator and fundraiser with extensive experience with the pharmaceutical industry. Those are some of the qualities the next Medicines Patent Pool executive director might have, according to a just-posted job announcement. The Patent Pool, which works with a range of partners to help increase access to HIV, hepatitis C and tuberculosis treatments in developments, negotiates voluntary licences with patent owners and develops patent pooling initiatives, according to the announcement. The Geneva-based agency, spun off from Unitaid several years ago but still funded by it, has saved the international community nearly $400 million, it said. The position opened up suddenly in December after the short-notice departure of Executive Director Greg Perry, who moved down the hill the next day to the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), as a generic drug specialist joining the brand-name pharma industry. The first executive director of the Medicines Patent Pool was health policy consultant Ellen ‘t Hoen. The announcement does not appear to state a deadline for applications. The full job announcement is available here and reprinted below: Organisation Overview The Medicines Patent Pool (MPP) is an independent public health foundation working to increase access to HIV, hepatitis C and tuberculosis treatments in developing countries through voluntary licensing and patent pooling initiatives. The foundation works with a broad spectrum of partners — industry, civil society organisations, international organisations, among others — to prioritise, forecast and license medicines and pool intellectual property to encourage generic manufacture and the development of novel formulations. Since its creation in 2010, the MPP has signed licensing agreements with nine patent holders for 13 HIV antiretrovirals, two hepatitis C antivirals and an investigational tuberculosis treatment. Leading pharmaceutical companies have signed licences with the foundation, and the MPP has signed sublicences with 20 generic manufacturers and product developers to produce these treatments. The MPP’s generic network has distributed more than five billion doses of World Health Organization-recommended and new medicines to low- and middle-income countries and is managing more than 130 projects to develop active pharmaceutical ingredients and formulations. To date, the MPP estimates that it has saved the international community US $391million in low-cost medicines through its licences. The MPP also has forged valuable partnerships with universities, international donor agencies, and governments in support of access to medicines objectives. In 2017, the MPP launched a feasibility study on the potential expansion of its licensing activities into other patented essential medicines with support from the Swiss Agency for Development and Cooperation (SDC). The MPP is currently developing its five-year strategic plan to further its standing as the world’s only patent pool and voluntary licensing mechanism in the public health space. The MPP’s model has received positive endorsements from the World Health Organization, the Access to Medicine Index, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), UNAIDS, the Lancet Commission on Essential Medicines for Universal Health Coverage, the United Nations High Level Panel on Access to Medicines, the governments of Belarus, France, Morocco, South Africa, Ukraine, the United States, and others. The MPP was founded by Unitaid and the organisation continues to fund its HIV, hepatitis C and tuberculosis activities. ___________________________________________________________________________________________________________________________________________ Location: Geneva, Switzerland Main Duties / Responsibilities The Executive Director leads the MPP and reports directly to the Governance Board. Responsibilities include: Guiding overall strategic direction of the organisation and ensuring execution of the MPP’s overall strategy; Overseeing licence negotiations with licensors and sub-licensees; Building strong collaborations and relationships with both public and private sector stakeholders, including national governments, United Nations agencies, corporations and civil society; Advocating for and representing the organisation in a range of settings worldwide; Leading donor relations and fundraising activities; Liaising with the Medicines Patent Pool’s two governance bodies – the Governance Board and the Expert Advisory Group; Managing the organisation’s staff members; Managing the organisation’s operations and finances. Experience and background The Executive Director must have: Minimum 15 years of experience in access to medicines and/or intellectual property in the public and/or private sectors; Extensive experience in, and/or engagement with, the pharmaceutical industry; Demonstrated ability to work effectively in international settings ranging from high-level diplomatic, including national governments and the United Nations, to corporate to grass-roots settings; A strong network of relevant contacts; Track record of forming strong external collaborations; Experience in donor relations; Experience in managing teams and budgets; Experience in pharmaceutical licensing negotiations with the private sector would be an advantage. Personal Qualities Leadership skills including setting strategic directions, managing external relations, managing staff, and facilitating meetings Strong negotiation skills Good advocacy skills Superior oral, written and interpersonal communication skills Willingness to travel – approximately 30% of the Executive Director’s time Sensitivity to different cultures and work styles Demonstrated commitment to public health and to the goals of the Medicines Patent Pool Education Advanced university degree in a related field required. Languages: Fluency in English is required. Oral and written proficiency in a second UN language is strongly desirable. It is the policy and practice of the Medicines Patent Pool to provide equal employment to qualified individuals (employees and applicants) regardless of their race, colour, religion, sex, sexual orientation, nationality, ethnic origin, marital status, disability, and to conform to all applicable laws and regulations. Salary is commensurate with experience. The Medicines Patent Pool offers a competitive compensation package, including social benefits. When applying for the position, please indicate whether you currently have Swiss employment authorization. Please send a cover letter and C.V. to firstname.lastname@example.org. Only short-listed candidates will be contacted. Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) Related William New may be reached at email@example.com."Medicines Patent Pool Launches Search For Next Director" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.